Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells

Journal of Periodontal Research

Volumn 46, Issue 4, 2011, Pages 427-437

  Lei, L ^a   Li, H ^a   Yan, F ^a,b   Li, Y ^a   Xiao, Y ^b  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Atherosclerosis; Foam cells; Lipopolysaccharide; Porphyromonas gingivalis

Indexed keywords

AUTACOID; CELL ADHESION MOLECULE; CELL RECEPTOR; CHEMOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL LINE; CULTURE TECHNIQUE; DRUG EFFECT; FOAM CELL; GENE EXPRESSION; GENETICS; HUMAN; MACROPHAGE; MONOCYTE; OXIDATION REDUCTION REACTION; PORPHYROMONAS GINGIVALIS;

APOPTOSIS; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CELL CULTURE TECHNIQUES; CELL LINE; CHEMOKINE CCL2; CHEMOKINES; FOAM CELLS; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES; MONOCYTES; NF-KAPPA B; OXIDATION-REDUCTION; PORPHYROMONAS GINGIVALIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 79959626144     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01356.x     Document Type: Article

References (24)

1. Gibson FC 3rd, Yumoto H, Takahashi Y, Chou HH, Genco CA. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J Dent Res 2006;85:106-121.
2. Demmer RT, Desvarieux M. Periodontal infections and cardiovascular disease: the heart of the matter. J Am Dent Assoc 2006;137(suppl):14S-20S; quiz 38S.
3. Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002;105:861-867.
4. Lalla E, Lamster IB, Hofmann MA et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23:1405-1411.
5. Gitlin JM, Loftin CD. Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice. Cardiovasc Res 2009;81:400-407.
6. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
7. Robbesyn F, Salvayre R, Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 2004;38:541-551.
8. Qi M, Miyakawa H, Kuramitsu HK. Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 2003;35:259-267.
9. Giacona MB, Papapanou PN, Lamster IB et al. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol Lett 2004;241:95-101.
10. Martin M, Katz J, Vogel SN, Michalek SM. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli. J Immunol 2001;167:5278-5285.
11. Janabi M, Yamashita S, Hirano K et al. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol 2000;20:1953-1960.
12. Gamble W, Vaughan M, Kruth HS, Avigan J. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978;19:1068-1070.
13. Zhou Q, Amar S. Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components. J Immunol 2007;179:7777-7790.
14. Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008;79:360-376.
15. Mikita T, Porter G, Lawn RM, Shiffman D. Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus. J Biol Chem 2001;276:45729-45739.
16. Groeneweg M, Kanters E, Vergouwe MN et al. Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL. J Lipid Res 2006;47:2259-2267.
17. Majdalawieh A, Ro HS. LPS-induced suppression of macrophage cholesterol efflux is mediated by adipocyte enhancer-binding protein 1. Int J Biochem Cell Biol 2009;41:1518-1525.
18. Oram JF, Wolfbauer G, Vaughan AM, Tang C, Albers JJ. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells. J Biol Chem 2003;278:52379-52385.
19. Ma KL, Ruan XZ, Powis SH, Moorhead JF, Varghese Z. Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2007;292:H2721-H2728.
20. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109(suppl):S81-S96.
21. Fischer C, Page S, Weber M, Eisele T, Neumeier D, Brand K. Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IkappaB kinase signalsome activation and IkappaB proteolysis. J Biol Chem 1999;274:24625-24632.
22. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005;25:904-914.
23. Diya Z, Lili C, Shenglai L, Zhiyuan G, Jie Y. Lipopolysaccharide (LPS) of Porphyromonas gingivalis induces IL-1beta, TNF-alpha and IL-6 production by THP-1 cells in a way different from that of Escherichia coli LPS. Innate Immun 2008;14:99-107.
24. Lu Q, Darveau RP, Samaranayake LP, Wang CY, Jin L. Differential modulation of human {beta}-defensins expression in human gingival epithelia by Porphyromonas gingivalis lipopolysaccharide with tetra- and penta-acylated lipid A structures. Innate Immun 2009;15:325-335.